Buehlmann


anti-GM1

...The expert's choice – your assay For motor neuropathies

test

Anti-GM1 antibodies:

Microtiter Plates of the anti-GM1-GM ELISA Kit are uniformly coated with GM1 antigen. There are many different options for using the plate and two are shown in Figures below:

 

 

Fig 1a

Indications for use of anti-GM1 ELISA
Antibodies to ganglioside M1 (GM1, anti-GM1). IgG antibodies) are implicated in the pathogenesis of Guillain-Barré Syndrome (GBS) and anti-GM1 IgM antibodies in multifocal neuropathy (MMN) and motor neuron disease (MND).
GM1 IgM antibodies may be present as monoclonal IgM paraprotein or as a polyclonal IgM. Polyclonal IgG may be detected in patients with motor neuropathies. High GM1 antibody titers may be detected in association with in Guillain-Barré Syndrome (GBS) following Campylobacter jejuni infection.
The fact that GM1 is the only common Glycolipid antigen reactive with all of the GM1 antibodies found in motor nerve disorders suggests that it is the relevant target antigen in neural tissue.

Product Information

anti-GM1-GM

Method

ELISA

Time to results

4.5 h

Sample Type

20 µl serum (1:50)

Standard range

quantitative new standardisation

Isotypes

IgG and gM

Order code

EK-GM1-GM 96 wells
CE

DOWNLOADS

Instruction
for use* for anti-GM1-GM

Clinical Information

Technical Information

English


[PDF 0.3MB]
- -

Deutsch

- -

Français

- -

Italiano

- -

* Multilingual document [EN, DE, FR, IT, ES]

Contact

BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch

Your local distributor
Order
About us
Job opportunities

News

NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND

BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb  more

New Seegene DPO Movie showing how this unique and proprietary technology is working to allow innovative multiplexing.

The unique and proprietary DPO™(Dual-Priming-Oligonucleotide) technology is the corner stone for all of the Seegene products, and it is the key to achieve  more

New EntroGen BRAF test (V600E/K/D) for the detection of important mutations found in melanoma on your real-time PCR instrument.

EntroGen has a new BRAF test that detects, beside the V600E mutation, also the V600K and the V600D, which are important mutations found in melanoma.   more

BÜHLMANN innovations and news at the JIB

At the JIB Congress in Paris, 8th – 10th November 2011, BÜHLMANN presents the MDx products of EntroGen and AutoGenomics as well as new developments of its  more

Get our RSS - Feed